INVESTOR ALERT: Class Action Lawsuit Against The Medicines Company Announced by Law Offices of Howard G. Smith
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all purchasers of the securities of The Medicines Company (NASDAQ:MDCO) between February 20, 2013 and February 12, 2014, inclusive (the “Class Period”).
The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The Company’s products include anticoagulants and treatments for blood pressure control and other cardiovascular indications. The complaint, filed in the United States District Court for the District of New Jersey, alleges that: (a) The Medicines Company issued materially misleading statements concerning the efficacy of its drug candidate Cangrelor, for preventing blood clots during angioplasty and stenting procedures, when compared to clopidogrel – a competing, FDA-approved drug; and (b) failed to disclose that the CHAMPION clinical trials of Cangrelor were unethically and inappropriately administered.
On February 13, 2014, the price of The Medicines Company shares dropped more than 11% after the Company announced that the Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee voted against approval of Cangrelor for patients undergoing certain cardiac procedures.
If you purchased The Medicines Company securities during the Class Period, you have until April 22, 2014, to move the Court to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.